Stanford spin-out Zenflow raises $31M to join the megamarket for enlarged prostate
Y Combinator graduate Zenflow has raised a $31.4 million Series A following a successful human trial of its Spring System in patients with benign prostatic hyperplasia (BPH) or enlarged prostate.